Home Inguinal lymphadenectomy in penile cancer patients: a comparison between open and video endoscopic approach in a multicenter setting
Article Open Access

Inguinal lymphadenectomy in penile cancer patients: a comparison between open and video endoscopic approach in a multicenter setting

  • Maida Bada , Felice Crocetto EMAIL logo , Peter Nyirady , Vincenzo Pagliarulo , Sebastiano Rapisarda , Antonio Aliberti , Stefano Boccasile , Matteo Ferro , Biagio Barone ORCID logo and Antonio Celia
Published/Copyright: March 20, 2023

Abstract

Objectives

To compare differences of operative outcomes, post-operative complications and survival outcomes between open and laparoscopic cases in a multicenter study.

Methods

This was a retrospective cohort study performed at three European centers from September 2011 to January 2019. The surgeon decision to perform open inguinal lymphadenectomy (OIL) or video endoscopic inguinal lymphadenectomy (VEIL) was done in each hospital after patient counselling. Inclusion criteria regarded a minimum follow-up of 9 months since the inguinal lymphadenectomy.

Results

A total of 55 patients with proven squamous cell penile cancer underwent inguinal lymphadenectomy. 26 of them underwent OIL, while 29 patients underwent VEIL. For the OIL and VEIL groups, the mean operative time was 2.5 vs. 3.4 h (p=0.129), respectively. Hospital stays were lower in the VEIL group with 4 vs. 8 days in OIL patients (p=0.053) while number of days requiring drains to remain in situ was 3 vs. 6 days (p=0.024). The VEIL group reported a lower incidence of major complications compared to the OIL group (2 vs. 17%, p=0.0067) while minor complications were comparable in both groups. In a median follow-up period of 60 months, the overall survival was 65.5 and 84.6% in OIL and VEIL groups, respectively (p=0.105).

Conclusions

VEIL is comparable to OIL regarding safety, overall survival and post-operative outcomes.

Introduction

Penile cancer (PC) is a rare malignant disease with an overall incidence of <1/100,000 in Western countries while constitutes up to 10% of malignancies in men in African, Asian and South American regions. Squamous cell carcinoma (SCC) accounts for more than 95% of PC cases [1], [2], [3]. Albeit several risk factors are associated with this malignancy, such as the presence of phimosis, smoking and low social economic status, the incidence of PC is mostly related to the prevalence of human papilloma virus (HPV) in the population with at least one-third of cases that could be attributed to HPV-related carcinogenesis [4, 5]. The presence and the extent of metastasis to the inguinal region, which occurs in 20–40% of PC patients, are the most important prognostic factors for survival in PC patients with SCC, representing one of the strongest predictors of mortality [6]. Inguinal lymphadenectomy (IL) alone can be curative and is therefore recommended [7, 8]. Unlike many other genitourinary tumors, which require systemic therapeutic strategies once metastasis has occurred, the characteristics of penile SCC, exhibiting a prolonged loco regional phase before distant dissemination, provide a rationale for the therapeutic value of IL [9].

The European Association of Urology (EAU) guidelines recommended IL in stages more than T1b G2 and in cases of palpable inguinal lymph nodes [10]. Nevertheless, there are two important issues: first, the risk of micrometastasis, which could be up to 25%, especially among patients with clinically negative groins; second, the risk associated with IL which may result in postoperative complications [11]. Albeit the introduction of sentinel lymph node dissection has prevented IL in 76% of patients, the procedure is still needed in order to assess lymph nodes status [12]. The open approach during IL (OIL) has been the gold standard management and, due to the improvement of surgical techniques in the last 10 years, the morbidity has been reduced to 30% for diagnostic IL (in the absence of nodal metastasis) and to 24–29% for therapeutic IL (in the presence of nodal metastasis) [13]. In the age of the minimally invasive approach, the video endoscopic IL (VEIL) emerged as a valid and feasible option that includes all the benefits of minimally invasive surgery in reducing the morbidity related to IL [14]. The aim of our study is to compare the differences in operative outcomes, postoperative complications and survival outcomes between OIL and VEIL in a multicenter series.

Materials and methods

Study design

This was a retrospective cohort study performed at three European centers from September 2011 to January 2019. Local Institutional Review Board approved the study at each participating center, which was: Hospital San Bassiano, Bassano del Grappa, Italy; Semmelweis University, Budapest, Hungary; University of Naples “Federico II”, Naples, Italy. Inclusion criteria were staging and treatment of primary tumor with partial or total penectomy 4 weeks before IL and minimum follow-up of 9 months since the IL. Exclusion criteria were: distant metastatic disease, skin involvement and prior history of surgery or radiotherapy in the inguinal or thigh region. The decision to perform OIL or VEIL was done in each hospital by the surgeon with the patient after explaining the costs, technique and complications of each approach. We collected data about patients’ characteristics in addition to pre-operative and operative data, which included complications rate, number of lymph nodes removed and survival outcomes. In each center, the surgical team performing both surgical approaches remained constant during the study period, with an experienced laparoscopic surgeon (>100 OIL and >150 VEIL) for the surgical team.

Preoperative and perioperative workup

The EAU Guidelines were used in order to follow a unique management pre- and post-operative in each center. Before the surgery, all patients of both groups followed the same pre-operative workup with a single dose of cefazolin 30 min before surgery and heparin prophylaxis. On postoperative day 1, all patients were given low molecular weight heparin and lower limb stockings. Drains were left in situ up to patient discharge and removed after output was less than 50 mL per day. The Clavien Dindo classification was used to assess complications, divided into minor (grades 1 and 2) and major (> grade 3a) [15].

Surgical technique

General anaesthesia was administered to the patients. Patients were in the supine position with the head 15° lower compared to the hip. Both lower extremities were straightened and abducted by about 45° (scissor position). Both knee joints were slightly flexed and rotated externally, with the catheter indwelled. The OIL was performed via the (inverse) S-shaped inguinal incision. In the VEIL approach, a 10-mm optical trocar and two 5-mm operating trocars were placed. The optical trocar was placed in the apex of Scarpa’s triangle after the skin incision and the creation of a subcutaneous space by blunt finger dissection. The pCO2 was 8–10 mmHg. The surgical technique is the same in both techniques, and it involved the removal of superficial and deep lymph nodes according to the scheme described by Deshler, sparing main venous structures [16]. All lymphadenectomies were performed unilaterally.

Follow up

Patients were followed according to the EAU guidelines, including a physical examination of penis and groins for local and/or regional recurrence. Radiological assessment was performed at three months intervals for the first two years [10, 17].

Statistical analysis

Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) v. 19.0 (IBM Inc., Armonk, NY, USA). Data are shown as means ±standard deviation (SD), as medians (range), or as numbers (percentage). The normality of data was assessed via the Kolmogorov–Smirnov test. Univariate comparisons of dichotomous data were performed with the use of the chi-square with continuity correction. Comparisons between groups were performed with the use of the t-test to test group means with SD by assuming equal within-group variances. Kaplan–Meyer curves were analyzed to characterise survival outcomes. We calculated two-sided p-values. A p-value <0.05 was considered to indicate statistical significance.

Results

A total of 55 patients underwent IL for PC diagnosis. In particular, 26 and 29 patients underwent OIL and VEIL, respectively. Descriptive characteristics of patients involved, including clinical, demographic and lymph nodal data are reported in Table 1. The median age at diagnosis was older in the VEIL group with 62.17 vs. 59.31 years of the OIL group. The OIL group showed, in addition, a higher prevalence of circumcised patients (61.5%) compared to the VEIL group (34.5 and 24.1%, respectively). However, the two groups were otherwise comparable in terms of diabetes, smoking status, body mass index and cardiovascular disease. The primary lesion was more frequently localized on the glans plus foreskin in both groups, with 46.2 and 44.8% in the OIL and VEIL groups, respectively. Palpable lymph nodes and positive pre-operative PET-CT concerning inguinal lymph nodes were reported in over 50% of patients in both groups. All specimens were SCC and the groups were comparable for the type of surgery, pathological T status, grading, lymph and vascular invasion of the primary lesion. Positive surgical margins were found in 7.79 and 10.3% of patients of OIL and VEIL group, respectively. Table 2 described lymph nodes management and pathological status. The average superficial lymph nodes yield per groin exceeded 10 and was similar in both treatment groups. In 7 cases, pelvic and inguinal lymph nodes were removed in the same operative session. Regarding nodal status, 46.2% of patients of OIL group and 31% of VEIL group were pN0. None of the patients treated with VEIL experienced any intraoperative event requiring deviation from the planned surgical technique or conversion to open surgery. Recurrence rates were comparable between both groups with 53.8% of OIL and 34.5% of VEIL (p=0.148). In particular, local recurrence was most frequent in the OIL group compared to the VEIL group (38.5 vs. 10.3%), while pelvic lymph nodal recurrence was higher in the VEIL group, with 17.2 vs. 3.8% of the OIL group. Operative and postoperative data were described in Figure 1. As concerning operative time, it was significantly higher in VEIL compared to OIL, with 3.4 vs. 2.5 h, respectively (p=0.129). Conversely, patients who underwent VEIL had a significantly shorter median hospital stay (4 vs. 8 days, p=0.053) and number of days requiring drains to remain in situ (3 vs. 6 days, p=0.024). Regarding postoperative complications, more than 75% of patients in both groups experienced some degree of complications, although major complications rates were overall low. In particular, patients treated with VEIL experienced a significantly lower incidence of major complications, reported as Clavien–Dindo grade 3, (2 vs. 17%, p=0.0067), which included edge necrosis (9.8 vs. 23%, p=0.048), flap necrosis (2 vs. 13%, p=0.035) and severe limb edema (0 vs. 9%, p=0.029). Minor complications reported as Clavien–Dindo grade 1–2 were comparable in both groups, including lymphocele, surgical site infection, cellulitis and early/late limb edema. In the VEIL group indeed 30% of patients reported minor complications, which included local wound complications, minor leg edema or lymphocele non-interfering with ambulation and cellulitis. In the OIL group, 27.5% of patients had similar minor postoperative complications, including leg lymphedemas, local wound complications and minor flap necrosis. Finally, Figure 2 shows the Kaplan–Mayer related to penile cancer recurrence, reporting, in a median follow-up period of 60 months, an overall survival of 65.5% for OIL and 84.6% for VEIL (p=0.105).

Table 1:

Demographic, clinical and tumor characteristics.

OIL VEIL p-Value
Number of patients 26 29
Age at diagnosis mean (median – Std) 59.31 (59–9.895) 62.17 (60–11.769) 0.357
No of circumcision, % 16 (61.5) 7 (24.1) 0.005
Smokers, % 16 (61.5) 10 (34.5) 0.45
Diabetes, % 3 (11.5) 7 (24.1) 0.226
Cardiovascular disease, % 3 (11.5) 5 (17.2) 0.549
Body mass index, kg/m 2 (median, IQR) 26 (23.3–30.6) 25.7 (23.1–29.1) 0.68
Site of neoplasm, % 0.172
Glans 12 (46.2) 10 (34.5)
Foreskin 1 (3.8) 6 (20.7)
Glans+Foreskin 12 (46.2) 13 (44.8)
Palpable lymphnodes, % 14 (53.8) 13 (46.4) 0.586
Positive PET-TC, % 17 (65.4) 16 (55.2) 0.440
Type of surgery, % 0.227
Circumcision 1 (3.8) 6 (20.7)
Local excission 6 (23.1) 6 (20.7)
Glansectomy 9 (34.6) 7 (24.1)
Partial penectomy 8 (30.8) 5 (17.2)
Total penectomy 2 (7.7) 5 (17.2)
Pathological status T, % 0.556
Tis 0 (0) 2 (6.9)
pT1A 10 (38.5) 9 (31)
pT1B 6 (23.1) 4 (13.8)
pT2 6 (23.1) 9 (31.8)
pT3 4 (15.4) 5 (17.2)
Grading, % 0.803
G1 4 (15.4) 4 (13.8)
G2 16 (61.5) 16 (55.2)
G3 6 (23.1) 9 (31)
Vascular invasion +, % 12 (46.2) 10 (34.5) 0.378
Lymphovascular invasion +, % 5 (19.2) 10 (34.59 0.361
Surgical margins +, % 2 (7.79) 3 (10.3) 0.733
  1. Statistically significant values (p<0.05) are reported in bold.

Table 2:

Lymph nodes management and pathological status.

OIL VEIL p-Value
Number of superficial LN mean (median – SD) 12.08 (12–3.428) 12.28 (12–5.021) 0.097
Number of deep LN mean (median – SD) 3.12 (4–2.673) 4.52 (3–4.904) 0.008
Positive superficial LN, % 16 (61.5) 19 (65.5) 0.759
Positive deep LN, % 5 (19.2) 2 (6.9) 0.64
Positive pelvic lymphnodes, % 8 (30.8) 8 (27.6) 0.795
Removed in the same session, % 7 (26.9) 7 (24.1) 0.813
Nodal status, % 0.142
pN0 12 (46.2) 9 (31)
pN1 5 (19.2) 13 (44.8)
pN2 9 (34.6) 7 (24.1)
Metastasis, % 0.560
M0 23 (88.5) 27 (93.1)
M1 2 (7.7) 2 (6.9)
M2 1 (3.8) 0 (0)
Recurrence, % 14 (53.8) 10 (34.5) 0.148
Type of recurrence, % 0.131
Local 10 (38.5) 3 (10.3)
Pelvic lymph nodes 1 (3.8) 5 (17.2)
Systemic disease 3 (11.5) 2 (6.9)
Chemotherapy, % 9 (34.6) 6 (20.7) 0.008
Radiotherapy, % 0 (0) 1 (3.4) 0.431
  1. LN, lymph nodes; SD, standard deviation.

Figure 1: 
Operative and postoperative data.
Figure 1:

Operative and postoperative data.

Figure 2: 
Kaplan–Mayer associated with penile cancer recurrence in OIL and VEIL (p=0.105).
Figure 2:

Kaplan–Mayer associated with penile cancer recurrence in OIL and VEIL (p=0.105).

Discussion

In the recent years, in order to reduce the morbidity associated to surgical complications after IL, a minimally invasive approach has been used in several centers. Since the first technique description by Tobias–Machado et al., the VEIL approach has decreased the morbidity of open conventional technique, maintaining oncological radicality [18, 19]. In further studies published, Sotelo et al. have described VEIL like a safe and feasible technique that appears to diminish the wound-related complications associated with the standard OIL [20]. Nevertheless, VEIL technique was accompanied by report of inguinal recurrence at follow up [21, 22]. However, in a study by Tobias–Machado et al. that described patients who underwent OIL on one side and VEIL on the other side, the number of lymph nodes removed were similar on both sides and no differences in progression or disease relapse was found after 18 months of follow up [23]. In a recent meta-analysis published by Hu et al. which included seven studies, the pooled OR for recurrence rate showed no difference between OIL and VEIL groups (OR=1.54, 95% CI [0.41, 5.84], p=0.530) [24]. In our multicenter experience, recurrence rate and patients’ overall survival were comparable in both groups, after a median follow of 5 years while local recurrence was most frequent in OIL group. Nevertheless, pelvic lymph nodes recurrence was more common in VEIL group, although not statistically significant.

As concerning the operative time, as reported in the literature, VEIL technique prolonged the duration of surgery procedure compered to OIL (134.82 vs. 116.53 min) [25]. The main reason is related to the learning curve of VEIL procedure, complicated by the rarity of PC [26]. Regarding the robotic approach experience in IL, operative time was similarly higher than OIL (75 vs. 60 min) but lower than VEIL (91 vs. 165 min); indicating quicker ability to dissect after the robot is docked in place [6]. In our case series, we reported an average difference in the two groups of about 50 min, slightly higher than that reported in the literature. The main reason for this increased operative time could be related to the multicenter design of our study and the different learning curve of the surgeons involved. Several studies reported that the length of hospital stay was reduced in the VEIL group. In particular, these values ranged from 4 to 24.3 days and from 2.5 to 15.8 days in OIL and VEIL groups, respectively [24]. This is confirmed by a recent study published by Yadav et al. and, similarly, by our series which reported a halved hospital stay of VEIL patients compared to OIL patients [27].

After the IL procedures, the drain tube represents an important way to control the quantity and quality of the output. Yadav et al. removed the drain tube when the daily output was less than 20 mL [27]. Nevertheless, Wang et al. removed the drainage tube when the daily output was less than 50 mL for 2 days [28]. In both published series, the drain was removed early in the VEIL group. According to Wang et al., we removed the drain after output was less than 50 mL per day, reporting an early removal of the drain tube (three days before, on average) in VEIL patients compared to OIL [26].

IL is historically associated with a high complication rate between 45 and 57% in patients undergoing this procedure as part of penile cancer management [29]. In particular, wound infection, skin necrosis (16.7–36% in OIL and 0–11.8% in VEIL groups) and lymphedema were the most common postoperative complications [24]. Nevertheless, the possibility of major complications such as deep vein thrombosis, led surgeons to search for less invasive methods [30, 31].To our knowledge, we are the first to report a series of patients when directly comparing OIL and VEIL in a multi-center cohort. This establishes the feasibility of both techniques in routine clinical practice, particularly concerning the complications rate. Major complication rate was lower in VEIL while those of OIL were similar to rates in contemporary cohorts, although the patients treated with OIL were significantly older [32]. With a laparoscopic approach, better preservation of skin lymphatics and vasculature due to smaller port incisions and atraumatic retraction by gas instead of by mechanical retractors and avoiding the need for sartorius muscle rotation due to incision placement at a distance from the great vessels may explain the significant lower observed incidence of lymphedema and skin related morbidity with VEIL [33]. In our clinical series we do not have lymphedema and one skin necrosis in the VEIL group, but in the OIL group we had four lymphedemas and one necrosis that required surgical intervention. Wang series is according to our experience and reported these complications in half cases in the VEIL group [28]. Schwenter et al. published the major complications in the OIL series compared with one only major complication in the VEIL group [34]. Since Catalona et al. described the preservation of the internal saphenous vein during IL suggesting a reduction in morbidity, without oncological risks [35]. Transposing the sartorius muscle is one of the factors most strongly associated with moderate to severe wound complications with fascia lata preservation [36]. The number of dissected lymph nodes of the two groups in all included studies was greater than 7, which demonstrated that both groups achieved effective cancer control. Therefore, regarding the number of dissected lymph nodes, we can only conclude that there was no significant difference between the two groups according to current evidence [24]. The number of superficial and deep inguinal nodes varies from 10 to 15 and 0 to five in VEIL and OIL, respectively [36]. Lastly, despite a reduced hospital stay as well as complications rates, the use of VEIL and other similar video endoscopic techniques for inguinal lymphadenectomy must consider also the cost associated with these procedures. It is well known that a robotic assisted surgery has greater costs compared to the open approach being therefore an important limitation for small centers. On the other side, however, the possibility to reduce hospital stay and major complications could reduce, partly, this cost. Further studies are required in order to assess also the economical aspects of robotic surgery in the pattern of penile cancer management and inguinal lymphadenectomy [37, 38].

There are different limitations in our study which included the retrospective nature of our study, which could have led to possible information detection bias and missing data, and the relatively small sample size which could not permit further sub-analyses. In addition, the multicenter design, albeit permitted to enroll more cases, has the limitation of having different surgeons despite a similar surgical experience.

Conclusions

VEIL can reduce hospital stay and drainage time and is generally superior in terms of postoperative complications compared to OIL, reporting similar oncological outcomes in a multicenter real-life context. Further studies are required to assess the feasibility of the procedure according to risks and costs.


Corresponding author: Felice Crocetto, Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples “Federico II”, Naples, Italy, Phone: 3491300696, E-mail:

  1. Research funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission. Protocol/project development: MB. Data collection or management: MB, MF, SB, FC, PN, VP, BB, SR, AA and AC. Data analysis: FC, BB and MB. Manuscript writing/editing: MB, FC and BB. Manuscript overview: AC and AA.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: This retrospective study was approved by the institutional research ethics committee of institutions involved and performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.

References

1. Montes Cardona, CE, García-Perdomo, HA. Incidence of penile cancer worldwide: systematic review and meta-analysis. Revista panamericana de salud publica Pan Am J Publ Health 2017;41:e117. https://doi.org/10.26633/rpsp.2017.117.Search in Google Scholar

2. Thomas, A, Necchi, A, Muneer, A, Tobias-Machado, M, Tran, ATH, Van Rompuy, AS, et al.. Penile cancer. Nat Rev Dis Prim 2021;7:11. https://doi.org/10.1038/s41572-021-00246-5.Search in Google Scholar PubMed

3. Crocetto, F, Buonerba, C, Caputo, V, Ferro, M, Persico, F, Trama, F, et al.. Urologic malignancies: advances in the analysis and interpretation of clinical findings. Future Science OA 2021;7:FSO674. https://doi.org/10.2144/fsoa-2020-0210.Search in Google Scholar PubMed PubMed Central

4. Crocetto, F, Arcaniolo, D, Napolitano, L, Barone, B, La Rocca, R, Capece, M, et al.. Impact of sexual activity on the risk of male genital tumors: a systematic review of the literature. Int J Environ Res Publ Health 2021;18:8500. https://doi.org/10.3390/ijerph18168500.Search in Google Scholar PubMed PubMed Central

5. Soares, A, de Carvalho, IT, da Fonseca, AG, Alencar, AMJr., Leite, CHB, Bastos, DA, et al.. Penile cancer: a Brazilian consensus statement for low- and middle-income countries. J Cancer Res Clin Oncol 2020;146:3281–96. https://doi.org/10.1007/s00432-020-03417-1.Search in Google Scholar PubMed PubMed Central

6. Kumar, V, Sethia, KK. Prospective study comparing video-endoscopic radical inguinal lymph node dissection (VEILND) with open radical ILND (OILND) for penile cancer over an 8-year period. BJU Int 2017;119:530–4. https://doi.org/10.1111/bju.13660.Search in Google Scholar PubMed

7. Bada, M, Berardinelli, F, Nyiràdy, P, Varga, J, Ditonno, P, Battaglia, M, et al.. Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study. J Cancer Res Clin Oncol 2019;145:921–6. https://doi.org/10.1007/s00432-019-02864-9.Search in Google Scholar PubMed

8. Di Lorenzo, G, Perdonà, S, Buonerba, C, Sonpavde, G, Gigantino, V, Pannone, G, et al.. Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study. J Transl Med 2013;11:161. https://doi.org/10.1186/1479-5876-11-161.Search in Google Scholar PubMed PubMed Central

9. Chipollini, J, Azizi, M, Lo Vullo, S, Mariani, L, Zhu, Y, Ye, DW, et al.. Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection. BJU Int 2020;125:82–8. https://doi.org/10.1111/bju.14883.Search in Google Scholar PubMed

10. Hakenberg, OW, Compérat, EM, Minhas, S, Necchi, A, Protzel, C, Watkin, N. EAU guidelines on penile cancer: 2014 update. Eur Urol 2015;67:142–50. https://doi.org/10.1016/j.eururo.2014.10.017.Search in Google Scholar PubMed

11. Gopman, JM, Djajadiningrat, RS, Baumgarten, AS, Espiritu, PN, Horenblas, S, Zhu, Y, et al.. Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohort. BJU Int 2015;116:196–201. https://doi.org/10.1111/bju.13009.Search in Google Scholar PubMed

12. Jakobsen, JK, Krarup, KP, Sommer, P, Nerstrøm, H, Bakholdt, V, Sørensen, JA, et al.. DaPeCa-1: diagnostic accuracy of sentinel lymph node biopsy in 222 patients with penile cancer at four tertiary referral centres - a national study from Denmark. BJU Int 2016;117:235–43. https://doi.org/10.1111/bju.13127.Search in Google Scholar PubMed

13. Cindolo, L, Spiess, PE, Bada, M, Chipollini, JJ, Nyirády, P, Chiodini, P, et al.. Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study. World J Urol 2019;37:1649–57. https://doi.org/10.1007/s00345-018-2549-3.Search in Google Scholar PubMed

14. Pahwa, HS, Misra, S, Kumar, A, Kumar, V, Agarwal, A, Srivastava, R. Video Endoscopic Inguinal Lymphadenectomy (VEIL)--a prospective critical perioperative assessment of feasibility and morbidity with points of technique in penile carcinoma. World J Surg Oncol 2013;11:42. https://doi.org/10.1186/1477-7819-11-42.Search in Google Scholar PubMed PubMed Central

15. Dindo, D, Demartines, N, Clavien, PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae.Search in Google Scholar PubMed PubMed Central

16. Chiapparrone, G, Rapisarda, S, de Concilio, B, Zeccolini, G, Antoniutti, M, Celia, A. Saphenous-sparing laparoscopic inguinal lymphadenectomy. Int Braz J Urol Off J Braz Soc Urol 2018;44:645–6. https://doi.org/10.1590/s1677-5538.ibju.2017.0120.Search in Google Scholar PubMed PubMed Central

17. Kroon, BK, Horenblas, S, Lont, AP, Tanis, PJ, Gallee, MP, Nieweg, OE. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol 2005;173:816–9. https://doi.org/10.1097/01.ju.0000154565.37397.4d.Search in Google Scholar PubMed

18. Meneses, AD, Mattos, PAL, Eulálio, WMNF, Fé, TSM, Rodrigues, RMM, Tobias-Machado, M. Initial experience of video endoscopic inguinal Lymphadenectomy in a center located at northeast Brazilian region. Int Braz J Urol Off J Braz Soc Urol 2019;45:325-31, https://doi.org/10.1590/s1677-5538.ibju.2018.0521.Search in Google Scholar

19. Tobias-Machado, M, Tavares, A, Molina, WRJr., Zambon, JP, Medina, JA, Forseto, PHJr., et al.. Video endoscopic inguinal lymphadenectomy (VEIL): initial case report and comparison with open radical procedure. Arch Esp Urol 2006;59:849–52. https://doi.org/10.4321/s0004-06142006000800020.Search in Google Scholar PubMed

20. Sotelo, R, Sánchez-Salas, R, Carmona, O, Garcia, A, Mariano, M, Neiva, G, et al.. Endoscopic lymphadenectomy for penile carcinoma. J Endourol 2007;21:364–7. https://doi.org/10.1089/end.2007.9971.Search in Google Scholar PubMed

21. Thyavihally, YB, Dev, P, Waigankar, SS, Pednekar, A, Kulkarni, B, Sharma, A, et al.. Comparative study of perioperative and survival outcomes after video endoscopic inguinal lymphadenectomy (VEIL) and open inguinal lymph node dissection (O-ILND) in the management of inguinal lymph nodes in carcinoma of the penis. J Robot Surg 2021;15:905–14. https://doi.org/10.1007/s11701-020-01189-x.Search in Google Scholar PubMed

22. Correa, AF. Technical management of inguinal lymph-nodes in penile cancer: open versus minimal invasive. Transl Androl Urol 2021;10:2264–71. https://doi.org/10.21037/tau.2020.04.02.Search in Google Scholar PubMed PubMed Central

23. Tobias-Machado, M, Tavares, A, Ornellas, AA, Molina, WRJr., Juliano, RV, Wroclawski, ER. Video endoscopic inguinal lymphadenectomy: a new minimally invasive procedure for radical management of inguinal nodes in patients with penile squamous cell carcinoma. J Urol 2007;177:953–7. https://doi.org/10.1016/j.juro.2006.10.075.Search in Google Scholar PubMed

24. Hu, J, Li, H, Cui, Y, Liu, P, Zhou, X, Liu, L, et al.. Comparison of clinical feasibility and oncological outcomes between video endoscopic and open inguinal lymphadenectomy for penile cancer: a systematic review and meta-analysis. Medicine (Baltim) 2019;98:e15862, https://doi.org/10.1097/md.0000000000015862.Search in Google Scholar PubMed PubMed Central

25. Koifman, L, Hampl, D, Koifman, N, Vides, AJ, Ornellas, AA. Radical open inguinal lymphadenectomy for penile carcinoma: surgical technique, early complications and late outcomes. J Urol 2013;190:2086–92. https://doi.org/10.1016/j.juro.2013.06.016.Search in Google Scholar PubMed

26. Elbalka, SS, Taha, A, Srinivas, C, Hegazy, MAF, Kotb, SZ, Elnahas, W, et al.. Short-term surgical outcomes of standard and lateral video endoscopic inguinal lymphadenectomy: a multinational retrospective study. J Laparoendosc Adv Surg Tech 2020;30:373–7. https://doi.org/10.1089/lap.2019.0733.Search in Google Scholar PubMed

27. Yadav, SS, Tomar, V, Bhattar, R, Jha, AK, Priyadarshi, S. Video endoscopic inguinal lymphadenectomy vs open inguinal lymphadenectomy for carcinoma penis: expanding role and comparison of outcomes. Urology 2018;113:79–84. https://doi.org/10.1016/j.urology.2017.11.007.Search in Google Scholar PubMed

28. Wang, S, Du, P, Tang, X, An, C, Zhang, N, Yang, Y. Comparison of efficiency of video endoscopy and open inguinal lymph node dissection. Anticancer Res 2017;37:4623–8. https://doi.org/10.21873/anticanres.11863.Search in Google Scholar PubMed

29. Wen, S, Ren, W, Xue, B, Fan, Y, Jiang, Y, Zeng, C, et al.. Prognostic factors in patients with penile cancer after surgical management. World J Urol 2018;36:435–40. https://doi.org/10.1007/s00345-017-2167-5.Search in Google Scholar PubMed

30. Protzel, C, Alcaraz, A, Horenblas, S, Pizzocaro, G, Zlotta, A, Hakenberg, OW. Lymphadenectomy in the surgical management of penile cancer. Eur Urol 2009;55:1075–88. https://doi.org/10.1016/j.eururo.2009.02.021.Search in Google Scholar PubMed

31. Hegarty, PK, Dinney, CP, Pettaway, CA. Controversies in ilioinguinal lymphadenectomy. Urol Clin 2010;37:421–34. https://doi.org/10.1016/j.ucl.2010.04.005.Search in Google Scholar PubMed

32. Yuan, JB, Chen, MF, Qi, L, Li, Y, Li, YL, Chen, C, et al.. Preservation of the saphenous vein during laparoendoscopic single-site inguinal lymphadenectomy: comparison with the conventional laparoscopic technique. BJU Int 2015;115:613–8. https://doi.org/10.1111/bju.12838.Search in Google Scholar PubMed

33. Sommariva, A, Pasquali, S, Rossi, CR. Video endoscopic inguinal lymphadenectomy for lymph node metastasis from solid tumors. Eur J Surg Oncol 2015;41:274–81. https://doi.org/10.1016/j.ejso.2014.10.064.Search in Google Scholar PubMed

34. Schwentner, C, Todenhöfer, T, Seibold, J, Alloussi, SH, Mischinger, J, Aufderklamm, S, et al.. Endoscopic inguinofemoral lymphadenectomy--extended follow-up. J Endourol. 2013;27:497–503, https://doi.org/10.1089/end.2012.0489.Search in Google Scholar PubMed

35. Catalona, WJ. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. J Urol 1988;140:306–10. https://doi.org/10.1016/s0022-5347(17)41589-8.Search in Google Scholar PubMed

36. Yao, K, Zou, ZJ, Li, ZS, Zhou, FJ, Qin, ZK, Liu, ZW, et al.. Fascia lata preservation during inguinal lymphadenectomy for penile cancer: rationale and outcome. Urology 2013;82:642–7. https://doi.org/10.1016/j.urology.2013.05.021.Search in Google Scholar PubMed

37. Elsamra, SE, Poch, MA. Robotic inguinal lymphadenectomy for penile cancer: the why, how, and what. Transl Androl Urol 2017;6:826–32. https://doi.org/10.21037/tau.2017.06.05.Search in Google Scholar PubMed PubMed Central

38. Rodrigues, GJ, Guglielmetti, GB, Orvieto, M, Seetharam Bhat, KR, Patel, VR, Coelho, RF. Robot-assisted endoscopic inguinal lymphadenectomy: a review of current outcomes. Asian J Urol 2021;8:20–6. https://doi.org/10.1016/j.ajur.2020.08.001.Search in Google Scholar PubMed PubMed Central

Received: 2023-02-09
Accepted: 2023-02-25
Published Online: 2023-03-20

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Investigating periprostatic adipose tissue as a driving force of prostate cancer progression: a new source of information for the advancement of targeted therapy in metastatic prostate cancer
  4. Reviews
  5. Pathophysiological effects of cadmium(II) on human health-a critical review
  6. The role of synbiotics in improving inflammatory status in nasopharyngeal carcinoma patients
  7. Anti-ageing effects of FDA-approved medicines: a focused review
  8. Diagnosis and management of uterine fibroids: current trends and future strategies
  9. Importance of moderate-to-vigorous physical activity during the COVID-19 pandemic: a systematic review and meta-analysis
  10. Original Articles
  11. Healthcare workers’ knowledge of evidence-based guidelines for prevention of ventilator-associated pneumonia in Hodeida, Yemen
  12. Comparison of cardiac autonomic function across complete glycaemic spectrum
  13. Prognostic value of heart rate variability in acute coronary syndrome
  14. Insights into the protective capacity of human dental pulp stem cells and its secretome in cisplatin-induced nephrotoxicity: effects on oxidative stress and histological changes
  15. Caffeine impairs anticonvulsant effects of levetiracetam in the maximal electroshock seizure threshold test in mice
  16. Antioxidant activity in off and on-pump coronary artery bypass grafting and valve replacement surgery
  17. A drug utilisation pattern in non-dialysis patients of diabetic nephropathy in a government-run tertiary care hospital in South-Asia
  18. Inguinal lymphadenectomy in penile cancer patients: a comparison between open and video endoscopic approach in a multicenter setting
  19. A randomized controlled trial to evaluate the efficacy of electrical vestibular nerve stimulation (VeNS), compared to a sham control for the management of sleep in young adults
  20. Short Communication
  21. The role of Bruton’s kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinib
  22. Letter to the Editor
  23. A hypothesis that Notopterol may be effective in COVID-19 via JAK/STAT and other signaling pathways
Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2023-0038/html
Scroll to top button